Mind Medicine Mindmed Inc
(NQ:
MNMD
)
6.010
+0.065 (+1.09%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Mind Medicine Mindmed Inc
< Previous
1
2
3
4
5
Next >
MindMed to Participate at Upcoming Investor Conferences
June 01, 2023
From
Mind Medicine
Via
Business Wire
FCM Pledges to Lock Up its MindMed Shares Until June 2025 to Demonstrate its Alignment with Fellow Shareholders and Confidence in its Plan to Restore MindMed
May 30, 2023
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
FCM Concerned MindMed’s Mismanagement Threatens Mental Health for Millions
May 25, 2023
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
MindMed Releases Investor Presentation Highlighting How the Company is Unlocking the Power of Psychedelics for Patients and Shareholders
May 25, 2023
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed Publishes Report by Leading FDA Experts Validating MindMed’s MM-120 Drug Development Strategy
May 25, 2023
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed to Present Data on the Preclinical Activity of MM-402 at the American Society of Clinical Psychopharmacology (ASCP) 2023 Annual Meeting
May 24, 2023
From
MindMed
Via
Business Wire
MindMed Announces Enrollment Milestone in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD)
May 17, 2023
From
MindMed
Via
Business Wire
FCM Director Nominees Will Put MindMed Drug Development Process Back on Track
May 15, 2023
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
FCM Releases Letter to Fellow MindMed Shareholders Highlighting Board and Management’s Track Record of Shareholder Value Destruction
May 05, 2023
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
MindMed Reports First Quarter 2023 Financial Results and Business Highlights
May 04, 2023
From
MindMed
Via
Business Wire
MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy
May 02, 2023
From
MindMed
Via
Business Wire
MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update
May 01, 2023
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed to Participate in May Investor Conferences
April 26, 2023
From
MindMed
Via
Business Wire
FCM Nominates Exceptional Director Candidates to Restore MindMed’s Value
April 21, 2023
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting
April 18, 2023
From
MindMed
Via
Business Wire
MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)
April 14, 2023
From
MindMed
Via
Business Wire
MindMed Appoints Mark R. Sullivan as Chief Legal Officer and Corporate Secretary
April 13, 2023
From
MindMed
Via
Business Wire
MindMed Reports Full Year 2022 Financial Results and Business Highlights
March 09, 2023
From
MindMed
Via
Business Wire
MindMed to Participate in March Investor Conferences
February 28, 2023
From
MindMed
Via
Business Wire
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry
January 26, 2023
EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Economy
Exposures
Supply Chain
Three Trends That May Shape the Psychedelics Industry Next Year
January 03, 2023
Via
Investor Brand Network
Activist Investor Informs MindMed of Financial Misstatements, Questions Internal Controls
November 14, 2022
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
Significant MindMed Investor Demands Federal Investigation to Probe Serious Allegations of Misconduct
November 03, 2022
From
Concerned Shareholders of Company MindMed
Via
GlobeNewswire
Psychedelic Drugs Prove Their Worth In Clinical Trials
October 11, 2022
Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial...
Via
PressReach
Colorado to Vote on Legalizing Psychoactives in November
October 05, 2022
Voters in Colorado will have a say in the legalization of psychedelic drugs this November as an initiative to legalize psilocybin mushrooms and other naturally occurring psychedelics appears on the...
Via
PressReach
Topics
Supply Chain
Exposures
Supply Chain
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
September 22, 2022
Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminalized psychedelics, a meeting was held by the City...
Via
PressReach
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
September 22, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one...
Via
FinancialNewsMedia
Psychedelics May Make People Less Afraid of Death
September 07, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 7, 2022 – According to a new survey by Johns Hopkins Medicine researchers, people’s attitudes toward death change...
Via
FinancialNewsMedia
Topics
Supply Chain
Exposures
Supply Chain
Study Suggests LSD May Boost Learning, Memory by Enhancing Neural Plasticity
August 18, 2022
Via
Investor Brand Network
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
August 10, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study...
Via
FinancialNewsMedia
Topics
Supply Chain
Exposures
Supply Chain
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.